Skip
Current Issue
This Month's Print Issue

Follow Fast Company

We’ll come to you.

1 minute read

Fast Feed

23andMe Parkinson's Disease Discovery To Get Patent Approval

Google-backed personalized genomics company 23andMe is expecting approval for its very first patent, inspired by a discovery about Parkinson's disease that the company's research staff made in October last year. They identified a genetic variant that could protect people with a certain kind of mutation that put them at risk of developing Parkinson's disease. Identifying the variant is a first step to developing a treatment for the disease. 23andMe is continuing work on the variant in collaboration with the Michael J. Fox Foundation for Parkinson's Research, co-founder Anne Wojcicki wrote in a blog post—work that could one day find use in drugs developed by biotech companies and pharmaceuticals. 23andMe has been cultivating a patient community and database of information about Parkinson's among its members for about a year now. Parkinson's is of particular interest to Wojcicki's husband and 23andMe backer Sergey Brin, who has been a strong supporter of Parkinson's research since 2005 and also carries a gene for the condition. 

To keep up with news as it happens, check in on our main Fast Feed page.

ARE YOU REGISTERED TO VOTE?
Register now to make sure you have a voice in the election.
loading